The war in Ukraine has massively impacted clinical trials. We spoke to one man tracking the disruption.

From improving solubility and bioavailability to making formulations suitable for inhalation – micronization is a versatile technique.

The Medicine Maker is proud to present the Power List 2022 and the inaugural Company of the Year Awards

Viral vector manufacture has come a long way, but the story is far from over.

Clinical trials suffer from heavy dropout rates. Perhaps the answer is a little care and attention.

PCI has focused on becoming a trusted CDMO partner by building strong working relationships with clients.

Cytiva is transforming in the wake of COVID-19 – but what lessons can the wider biopharma industry take forward?

More researchers are exploring the potential of mRNA encapsulation into lipid nanoparticles.

What happened in April in the biopharma industry? Here’s our roundup of the biggest headlines and research.

In our second C+G Champions installment, we ask industry leaders in the cell and gene field to answer key questions about the industry.